Created at	Source	Raw Value	Validated value
Jan. 16, 2022, 10:30 a.m.	usa	Stage II: Percentage of Participants Who Were Alive (i.e., not died due to any reason) at Day 29;Stage I: Number of Participants with Treatment Emergent Adverse Events Graded as Assessed by CTCAE Version 4.0	Stage II: Percentage of Participants Who Were Alive (i.e., not died due to any reason) at Day 29;Stage I: Number of Participants with Treatment Emergent Adverse Events Graded as Assessed by CTCAE Version 4.0
Oct. 26, 2020, 11:31 p.m.	usa	Number of Participants with Treatment Emergent Adverse Events Graded as Assessed by CTCAE Version 4.0	Number of Participants with Treatment Emergent Adverse Events Graded as Assessed by CTCAE Version 4.0